A Randomized Controlled Trial Evaluating Different Doses of Oral Zinc Supplementation in Combination With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma
PHASE2
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
PHASE2
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer (CASTLE-08)
PHASE2
The objective of this study is to evaluate the efficacy and safety of cryoa...